Cargando…
SABCS 2021 Insights on Breast Cancer Research: An Interview with Dr. Laura Spring
Laura Spring, MD, a clinical investigator and breast medical oncologist at Massachusetts General Hospital Cancer Center and Harvard Medical School, shared insights on breast cancer research presented at the 2021 San Antonio Breast Cancer Symposium (SABCS).
Autor principal: | Jacobson, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963143/ https://www.ncbi.nlm.nih.gov/pubmed/35348785 http://dx.doi.org/10.1093/oncolo/oyac008 |
Ejemplares similares
-
Pyrotinib Improves Survival in Previously Treated HER2-Positive Metastatic Breast Cancer
por: Jacobson, Anne
Publicado: (2022) -
Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast Cancer
por: Jacobson, Anne
Publicado: (2022) -
Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast Cancer
por: Jacobson, Anne
Publicado: (2022) -
Ribociclib Improves Overall Survival in HR+/HER2– Metastatic Breast Cancer Across Common Genomic and Clinical Subtypes
por: Jacobson, Anne
Publicado: (2022) -
Early Switch to Fulvestrant Plus Palbociclib Improves Outcomes in ESR1-Mutated, Estrogen Receptor-Positive Metastatic Breast Cancer
por: Jacobson, Anne
Publicado: (2022)